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1 |  CASE REPORT
Patients with adrenal adenomas can develop subclinical 
Cushing's syndrome (SCS) due to an excess of cortisol pro-
duction, without the typical clinical signs and symptoms of 
Cushing's syndrome (CS).1 SCS often co-occurs with some 
diseases like obesity, diabetes mellitus, and hypertension.2 
When a woman's pregnancy is complicated by SCS, the dis-
ease course is not well known as SCS during pregnancy is 
rare. Here, we report a case of a pregnant woman diagnosed 
with SCS during the pregnancy, complicated with superim-
posed preeclampsia.
A 34-year-old woman, 3 gravida 2 para, was referred to 
our institution at 21 weeks of gestation with hypertension. 
She had no previous medical history. She had a normal 
blood pressure during her past two pregnancy. However, for 
her current pregnancy, her blood pressure suddenly raised 
to 170/91  mm Hg at 12  weeks of gestation. Physical ex-
amination at hospitalization revealed a blood pressure of 
170/110 mm Hg and a body mass index of 31.6 kg/m2. No 
clinical signs like buffalo hump, moon face, and striae were 
observed. Following hospitalization, her blood pressure 
ranged between 130-140 and 90-100 mm Hg with antihyper-
tensive therapy (Nifedipine 40 mg/day). The 24-hour urine 
total protein level was checked few times and showed nor-
mal data (198.0-293.2 mg). We suspected preexisting hyper-
tension. Hormonal profiles revealed a normal serum cortisol 
level of 15.5 (normal range 4.5-21.1 μg/dL) and a low plasma 
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Abstract
When we see preexistent hypertension in pregnancy, subclinical Cushing's syndrome 
should be considered in the differential diagnosis since this disorder can cause peri-
natal complications. MRI can be useful for identifying adrenal incidental tumors 
during pregnancy.
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F I G U R E  1  Computer tomography on postpartum day 3 (The 
yellow arrow shows a 28 mm × 28 mm right adrenal mass.)
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level of adrenocorticotropic hormone (ACTH) early in the 
morning of ＜1.5 (normal range 7.2-63.3 pg/mL). SCS was 
suspected. Following this, the total 24-hour urine protein 
level was found to be 11 g/day at 26 weeks of gestation, and 
diagnosis of superimposed preeclampsia was made. Blood 
test revealed low platelets (11.6 × 104/μL), elevated lactate 
dehydrogenase (437 U/L), and low AT3 (75%) at 27 weeks 
of gestation. The estimated fetal weight by ultrasonography 
was 820  g (−1.21  SD) at 25  weeks, 868  g (−0.97  SD) at 
26 weeks, and 846 g (−1.82 SD) at 27 weeks of gestation. 
The newborn was delivered at 28 weeks of gestation because 
of maternal partial hemolysis, liver enzymes, and low plate-
let count occurring in pregnancy (HELLP) syndrome and 
fetal growth arrest. A female infant weighing 793  g with 
Apgar score of 6 at 1 minute and 8 at 5 minutes was deliv-
ered by cesarean section. On postpartum day 3, computer 
tomography was performed and revealed a 28 mm × 28 mm 
right adrenal mass (Figure 1). Two weeks postpartum, hor-
monal profiles showed a normal serum cortisol level (6.1 μg/
dL) and a low plasma level of ACTH early in the morning 
(2.6 pg/mL) again. Serum cortisol after an overnight 1 mg 
dexamethasone suppression test was 3.3  μg/dL, and the 
ACTH level early in the morning was low (＜1.5 pg/mL), 
6 weeks following the delivery. We confirmed the diagnosis 
of SCS. Her blood pressure remained at 130-140/80-90 mm 
Hg, her creatinine level was 0.6-0.7 mg/dL, and urine pro-
tein/creatinine ratio was 0.7-0.9 after the delivery. Adosterol 
adrenal scintigraphy was performed 2  months postpartum 
(Figure 2). Uptake was observed only on the tumor side. A 
laparoscopic adrenalectomy is proposed to the patient. No 
neurodevelopmental difficulties have been identified in the 
infant.
There are serious maternal and fetal complications during 
pregnancy with CS, such as hypertension, gestational diabe-
tes, heart failure, spontaneous abortion, preterm labor, and 
fetal growth retardation.3 However, it is unclear whether such 
complications occur in pregnancies with SCS. The diagnosis 
of SCS during pregnancy is challenging, as in the case of 
CS, due to the similarities of some of its features with that 
of a normal pregnancy, accompanied by physiological hy-
percortisolism.4 Estrogen increase can promote cortisol 
binding coupled with increases in placental ACTH and cor-
ticotrophin-releasing hormone can lead to increases in free 
cortisol levels in plasma and the uterus.3 Moreover, SCS is 
asymptomatic, and the activity of the tumor varies among 
patients.1 This case was complicated by hypertensive disor-
der of pregnancy in the first trimester; however, the patient 
showed no sign of preeclampsia at this time. Following this, 
we suspected preexistent hypertension. The differential diag-
nosis for the cause of hypertension was an adrenal tumor, re-
novascular abnormalities and thyroid disease, and so on. We 
investigated her adrenal function, thyroid function, and renal 
function by blood tests not only during pregnancy but also 2 
and 6 weeks postpartum. Abnormal adrenal morphology and 
renovascular abnormalities were not detected by ultrasonog-
raphy during pregnancy. To identify the adrenal incidental 
tumor, MRI may be a better alternative than ultrasonography 
during pregnancy.
Laparoscopic adrenalectomy has become a standard ap-
proach for adrenal tumors.1 There are some studies that rec-
ommend surgical treatment for the management of CS during 
pregnancy.3,5 A surgical approach could be effective for SCS 
as well. In this case, the condition of SCS could have im-
proved if the adrenal tumor was found and laparoscopic adre-
nalectomy was performed during the pregnancy.
In conclusion, serious perinatal complications can occur 
due to SCS in pregnancy, such as presented in this case 
of CS. There is no consensus on the management of SCS 
during pregnancy due to the rarity of this condition. We 
hope this report will contribute to the evidence for under-
standing SCS.
CONFLICT OF INTEREST
The authors have no conflict of interest to declare.
F I G U R E  2  Adosterol adrenal scintigraphy on 2 months postpartum (There is an uptake only on the tumor side.)
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